Palatin Technologies (PTN) Interest Coverage Ratio (2010 - 2026)
Palatin Technologies' (PTN) quarterly Interest Coverage Ratio came in at 1246.84 in Q1 2026, up 53.5% YoY from 812.27 in Q1 2025, and up 91.53% on a QoQ basis from 14715.96 in Q4 2025.
Palatin Technologies (PTN) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 17 years of Interest Coverage Ratio data on file, last reported at 1246.84 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 53.5% year-over-year to 1246.84 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 898.59 (down 2633.01% YoY) and the FY2025 annual result came in at 0.25, up 30.77% from the prior year.
- Interest Coverage Ratio advanced to 1246.84 in Q1 2026, from 14715.96 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 2328.2 in Q3 2025 to a low of 14715.96 in Q4 2025.
- A 5-year average of 1701.98 and a median of 668.93 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio surged 14697.63% — and 2025, when it plunged 5406.7%.
- Tracing PTN's Interest Coverage Ratio over 5 years: stood at 5.01 in 2022, then jumped by 14697.63% to 730.93 in 2023, then sank by 193.94% to 686.65 in 2024, then sank by 2043.16% to 14715.96 in 2025, then jumped by 91.53% to 1246.84 in 2026.
- The last three Interest Coverage Ratio figures came in at 1246.84 (Q1 2026), 14715.96 (Q4 2025), and 2328.2 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - | -1,246.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,246.84 |
| Dec 31, 2025 | -14,715.96 |
| Sep 30, 2025 | 2,328.20 |
| Jun 30, 2025 | -651.21 |
| Mar 31, 2025 | -2,681.44 |
| Dec 31, 2024 | -686.65 |
| Sep 30, 2024 | -713.53 |
| Jun 30, 2024 | 12.27 |
| Mar 31, 2024 | -7,351.11 |
| Dec 31, 2023 | 730.93 |
| Sep 30, 2023 | -561.38 |
| Jun 30, 2023 | -27.90 |
| Dec 31, 2022 | -5.01 |
| Sep 30, 2022 | -911.55 |
| Jun 30, 2022 | -717.51 |
| Mar 31, 2022 | -32.95 |
| Dec 31, 2021 | -22.61 |
| Sep 30, 2021 | -38.61 |
| Jun 30, 2021 | -973.21 |
| Mar 31, 2021 | -3.98 |